Advertisement

Clinical trials with new oral anticoagulants

Journal: Hämostaseologie
ISSN: 0720-9355
Topic:

57. Jahrestagung der Gesellschaft für Hämostase- und Thromboseforschung e.V.
HÄMOSTASEOLOGIE INTERDISZIPLINÄR

DOI: http://dx.doi.org/10.5482/HAMO-12-11-0021
Issue: Issues of 2013 (Vol. 33): Issue 1 2013 (1-76)
Pages: 62-70

Clinical trials with new oral anticoagulants

Additive value of indirect comparisons also named network meta-analyses

J. Harenberg (1), C. Weiss (2)

(1) Department of Clinical Pharmacology, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany; (2) Department of Biometry and Statistics, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany

Summary

To compare the efficacy and safety of the new oral anticoagulants (NOAC), ideally head-to-head clinical trials should be performed. Given the expense of such an undertaking, it is highly unlikely that such a comparison would be performed. Therefore, there is a need for an unbiased comparative assessment of the benefits and risks of the NOACs, based on the available trial data. Indirect or mixed treatment comparisons may be an useful tool to overcome these limitations also known as network meta-analysis (NMA). The aim of this paper is to give an overview on published NMAs for dabigatran, rivaroxaban and apixaban, each assessed against warfarin in patients with atrial fibrillation, and against enoxaparin in patients undergoing total knee and total hip replacement surgery, in order to obtain insights into the comparability of the adopted methodological techniques.

Keywords

Atrial fibrillation, total hip replacement, oral anticoagulants, rivaroxaban, total knee replacement, dabigatran, Apixaban, prophylaxis of thromboembolism

DOI

http://dx.doi.org/10.5482/HAMO-12-11-0021

You may also be interested in...

1.
Additive value of indirect comparisons (network meta-analyses)

Free download of English version

J. Harenberg (1), C. Weiss (2), S. Marx (1), S. Zolfaghari (1)

Phlebologie 2013 42 3: 139-148

http://dx.doi.org/10.12687/phleb2146-3-2013

2.
An indirect comparison analysis

Online Supplementary Material

F. Skjøth (1, 2), T. B. Larsen (1, 2), L. H. Rasmussen (1, 2), G. Y. H. Lip (1, 3)

Thromb Haemost 2014 111 5: -

http://dx.doi.org/10.1160/TH14-02-0118

3.
Ready to be replaced?

J. Steffel (1), T. F. Luscher (1)

Hämostaseologie 2012 32 4: 249-257

http://dx.doi.org/10.5482/ha-12050008